ISRCTN15749766进行中（未招募）未知
Personalized primary prevention of cancer: The 3PC Study
CHU de Québec-Université Laval0 个研究点目标入组 120 人开始时间: 2022年7月5日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 120
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •Breast cancer-free adult women with one or more of the following characteristics :
- •1. Having a first-degree family history of breast cancer
- •2. Personal history of breast atypical hyperplasia
- •3. An extreme breast density
- •4. Being a mutation carrier in high or moderate penetrance genes.
- •Prostate cancer-free adult men with one or more of the following characteristics :
- •1. Being an African-descent origin
- •2. Being a BCRA1/2 mutation carrier
- •3. Having an elevated prostate-specific antigen.
- •4. Having a first-degree family history of prostate cancer.
排除标准
- •1. Personal history of any cancer
- •2. Participation in a clinical study on primary prevention of breast cancer and prostate cancer
- •3. Engaged in a decision-making process regarding breast cancer and prostate cancer preventive measures
研究者
相似试验
进行中（未招募）
不适用
Multicenter study on the genetic screening and diagnosis of deafness in ChinaGenetic deafnessGenetic DiseasesISRCTN10768387Chinese PLA General Hospital10,000
进行中（未招募）
不适用
A Phase 3 Clinical Study to Investigate the Prevention of Relapse in Lymphoma Using Daily Enzastaurin - N/Ahigh-risk diffuse large B-cell lymphoma (DLBCL )EUCTR2005-004630-41-DEEli Lilly and Company limited709
进行中（未招募）
不适用
A Phase 3 Clinical Study to Investigate the Prevention of Relapse in Lymphoma Using Daily Enzastaurin - PRELUDEHigh-risk diffuse large B-cell lymphoma (DLBCL)EUCTR2005-004630-41-GREli Lilly and Company Limited459
进行中（未招募）
不适用
A Phase 3 Clinical Study to Investigate the Prevention of Relapse in Lymphoma Using Daily Enzastaurin - Preludehigh-risk diffuse large B-cell lymphoma (DLBCL )EUCTR2005-004630-41-DKEli Lilly and Company limited709
进行中（未招募）
1 期
A Phase 3 Clinical Study to Investigate the Prevention of Relapse in Lymphoma Using Daily Enzastaurin - N/Ahigh-risk diffuse large B-cell lymphoma (DLBCL )MedDRA version: 14.1Level: HLTClassification code 10012819Term: Diffuse large B-cell lymphomasSystem Organ Class: 100000004851EUCTR2005-004630-41-CZEli Lilly and Company Limited709